[Thalidomide and cancer].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001551:Benz(a)Anthracenes; D002715:Chlormadinone Acetate / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005984:Glutethimide / Q000627:therapeutic use; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D008656:Mestranol / Q000627:therapeutic use; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000517:prevention & control; D010634:Phenobarbital / Q000627:therapeutic use; D051381:Rats; D012110:Reserpine / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001551:Benz(a)Anthracenes; D002715:Chlormadinone Acetate; D013792:Thalidomide; D012110:Reserpine; D003520:Cyclophosphamide; D008656:Mestranol; D005984:Glutethimide; D002746:Chlorpromazine; D010634:Phenobarbital
Thalidomid und Tumor.